These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33084192)

  • 21. Development and exploration of the content validity of a patient-reported outcome measure to evaluate the impact of migraine- the migraine physical function impact diary (MPFID).
    Hareendran A; Mannix S; Skalicky A; Bayliss M; Blumenfeld A; Buse DC; Desai PR; Ortmeier BG; Sapra S
    Health Qual Life Outcomes; 2017 Nov; 15(1):224. PubMed ID: 29149901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Qualitative Study to Develop and Evaluate the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures.
    Kitchen H; Gandhi K; Carmichael C; Wyrwich KW; Lukic T; Al-Zubeidi T; Marshall C; Pegram H; King S; King B
    Dermatol Ther (Heidelb); 2022 Aug; 12(8):1907-1924. PubMed ID: 35857279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development and validation of the CARe Burn Scale: Child Form: a parent-proxy-reported outcome measure assessing quality of life for children aged 8 years and under living with a burn injury.
    Griffiths C; Guest E; Pickles T; Hollèn L; Grzeda M; Tollow P; Harcourt D
    Qual Life Res; 2021 Jan; 30(1):239-250. PubMed ID: 32902793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary Ciliary Dyskinesia: First Health-related Quality-of-Life Measures for Pediatric Patients.
    Dell SD; Leigh MW; Lucas JS; Ferkol TW; Knowles MR; Alpern A; Behan L; Morris AM; Hogg C; DunnGalvin A; Quittner AL
    Ann Am Thorac Soc; 2016 Oct; 13(10):1726-1735. PubMed ID: 27464304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM).
    Brod M; Bushnell DM; Neergaard JS; Waldman LT; Busk AK
    J Patient Rep Outcomes; 2023 Feb; 7(1):17. PubMed ID: 36821002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Qualitative Assessment of the Symptoms and Impact of Pancreatic Exocrine Insufficiency (PEI) to Inform the Development of a Patient-Reported Outcome (PRO) Instrument.
    Johnson CD; Arbuckle R; Bonner N; Connett G; Dominguez-Munoz E; Levy P; Staab D; Williamson N; Lerch MM
    Patient; 2017 Oct; 10(5):615-628. PubMed ID: 28332032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality of life in adults with achondroplasia in the United States.
    Yonko EA; Emanuel JS; Carter EM; Raggio CL
    Am J Med Genet A; 2021 Mar; 185(3):695-701. PubMed ID: 33369042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the impact of growth hormone deficiency and treatment in adults: development of a new disease-specific measure.
    Brod M; Højbjerre L; Adalsteinsson JE; Rasmussen MH
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1204-12. PubMed ID: 24438372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and content validity of a hemodialysis symptom patient-reported outcome measure.
    Flythe JE; Dorough A; Narendra JH; Wingard RL; Dalrymple LS; DeWalt DA
    Qual Life Res; 2019 Jan; 28(1):253-265. PubMed ID: 30229532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring the Impact of Burn Injury on the Parent-Reported Health Outcomes of Children 1 to 5 Years: A Conceptual Framework for Development of the Preschool Life Impact Burn Recovery Evaluation Profile CAT.
    Brady KJS; Grant GG; Stoddard FJ; Meyer WJ; Romanowski KS; Chang PH; Painting LE; Fowler LA; Nelson JK; Rivas P; Epperson K; Sheridan RL; Murphy M; O'Donnell EH; Ceranoglu TA; Sheldrick RC; Ni P; Slavin MD; Warner P; Palmieri TL; Schneider JC; Kazis LE; Ryan CM
    J Burn Care Res; 2020 Jan; 41(1):84-94. PubMed ID: 31222201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Children with speech, language and communication needs: their perceptions of their quality of life.
    Markham C; van Laar D; Gibbard D; Dean T
    Int J Lang Commun Disord; 2009; 44(5):748-68. PubMed ID: 19107658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).
    Hareendran A; Skalicky A; Mannix S; Lavoie S; Desai P; Bayliss M; Thach AV; Mikol DD; Buse DC
    Headache; 2018 Nov; 58(10):1612-1628. PubMed ID: 30374958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Psychometric Evaluation of an Instrument Assessing Barriers to Growth Hormone Treatment (BAR-GHT).
    de Zwaan M; Fischer-Jacobs J; Wabitsch M; Reinehr T; Meckes-Ferber S; Crosby RD
    Front Endocrinol (Lausanne); 2020; 11():84. PubMed ID: 32158432
    [No Abstract]   [Full Text] [Related]  

  • 35. A recurring rollercoaster ride: a qualitative study of the emotional experiences of parents of children with juvenile idiopathic arthritis.
    Gómez-Ramírez O; Gibbon M; Berard R; Jurencak R; Green J; Tucker L; Shiff N; Guzman J
    Pediatr Rheumatol Online J; 2016 Mar; 14(1):13. PubMed ID: 26961237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing Children's Eudaimonic Well-Being: The PROMIS Pediatric Meaning and Purpose Item Banks.
    Forrest CB; Bevans KB; Filus A; Devine J; Becker BD; Carle AC; Teneralli RE; Moon J; Ravens-Sieberer U
    J Pediatr Psychol; 2019 Oct; 44(9):1074-1082. PubMed ID: 31233149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study.
    Maghnie M; Semler O; Guillen-Navarro E; Selicorni A; Heath KE; Haeusler G; Hagenäs L; Merker A; Leiva-Gea A; González VL; Raimann A; Rehberg M; Santos-Simarro F; Ertl DA; Gregersen PA; Onesimo R; Landfeldt E; Jarrett J; Quinn J; Rowell R; Pimenta J; Cohen S; Butt T; Shediac R; Mukherjee S; Mohnike K
    Orphanet J Rare Dis; 2023 Mar; 18(1):56. PubMed ID: 36922864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the impact of non-severe hypoglycemic events and treatment in adults: development of the Treatment-Related Impact Measure-Non-severe Hypoglycemic Events (TRIM-HYPO).
    Brod M; Højbjerre L; Bushnell DM; Hansen CT
    Qual Life Res; 2015 Dec; 24(12):2971-84. PubMed ID: 26094008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parents' Experience of Administering Vosoritide: A Daily Injectable for Children with Achondroplasia.
    NiMhurchadha S; Butler K; Argent R; Palm K; Baujat G; Cormier-Daire V; Mohnike K
    Adv Ther; 2023 May; 40(5):2457-2470. PubMed ID: 37017912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experiences of children and adolescents living with achondroplasia and their caregivers.
    Shediac R; Moshkovich O; Gerould H; Ballinger R; Williams A; Bellenger MA; Quinn J; Hoover-Fong J; Mohnike K; Savarirayan R; Kelly D
    Mol Genet Genomic Med; 2022 Apr; 10(4):e1891. PubMed ID: 35138050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.